The NOPHO-ALL-92 and ALL-2000 trials found that compared with an initial diagnosis of leukemia with no CNS involvement, an initial diagnosis of CNS leukemia was more frequent in patients with T-ALL, hyperleukocytosis, and BCR/ABL fusion gene positivity (19). The gene discussed is ABL1; the disease is acute lymphoblastic leukemia.